• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-甲基-5-(3-苯丙烯酰基)噻唑的设计、合成及神经氨酸酶抑制活性。

Design, synthesis and neuraminidase inhibitory activity of 4-methyl-5-(3-phenylacryloyl) thiazoles.

机构信息

College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China.

出版信息

Mol Divers. 2024 Jun;28(3):1129-1140. doi: 10.1007/s11030-023-10639-1. Epub 2023 Mar 23.

DOI:10.1007/s11030-023-10639-1
PMID:36959424
Abstract

A series of 4-methyl-5-(3-phenylacryloyl)thiazoles based on chalcones were designed, synthesized and evaluated for their influenza neuraminidase (NA) inhibitory activity in vitro. A preliminary structure-activity relationship (SAR) analysis showed that thiazoles bearing amide had greater potency. It also showed that mono-hydroxyl group at 4-position on phenyl ring was more effective than other electron-releasing groups or electron-withdraw groups. Compounds A2 and A26 were more potent against NA with IC values of 8.2 ± 0.5 μg/mL and 6.2 ± 1.4 μg/mL, respectively. Molecular docking study demonstrated that thiazoles skeleton was benefit for the NA inhibitory activity.

摘要

基于查耳酮的一系列 4-甲基-5-(3-苯基丙烯酰基)噻唑被设计、合成并评估了它们在体外对流感神经氨酸酶 (NA) 的抑制活性。初步的构效关系 (SAR) 分析表明,酰胺取代的噻唑具有更强的活性。它还表明,苯环上 4-位的单羟基比其他供电子基团或吸电子基团更有效。化合物 A2 和 A26 对 NA 的抑制活性更强,IC 值分别为 8.2±0.5μg/mL 和 6.2±1.4μg/mL。分子对接研究表明,噻唑骨架有利于 NA 的抑制活性。

相似文献

1
Design, synthesis and neuraminidase inhibitory activity of 4-methyl-5-(3-phenylacryloyl) thiazoles.4-甲基-5-(3-苯丙烯酰基)噻唑的设计、合成及神经氨酸酶抑制活性。
Mol Divers. 2024 Jun;28(3):1129-1140. doi: 10.1007/s11030-023-10639-1. Epub 2023 Mar 23.
2
Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.设计、合成及 4-噻唑啉酮衍生物作为流感神经氨酸酶抑制剂的生物活性评价。
Eur J Med Chem. 2021 Mar 5;213:113161. doi: 10.1016/j.ejmech.2021.113161. Epub 2021 Jan 12.
3
Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.设计并一锅合成噻唑基腙衍生物作为流感神经氨酸酶抑制剂。
Mol Divers. 2017 Aug;21(3):565-576. doi: 10.1007/s11030-017-9740-0. Epub 2017 May 23.
4
Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.设计、合成及噻唑衍生物作为新型流感神经氨酸酶抑制剂的生物活性。
J Enzyme Inhib Med Chem. 2011 Aug;26(4):506-13. doi: 10.3109/14756366.2010.534732. Epub 2010 Dec 14.
5
Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl.甲型和乙型流感病毒的神经氨酸酶易受化合物 4-(4-苯基-1H-1,2,3-三唑-1-基)-2,2,6,6-四甲基哌啶-1-氧基的影响。
Curr Top Med Chem. 2020;20(2):132-139. doi: 10.2174/1568026620666191227142433.
6
Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors.阿魏酸衍生物的流感神经氨酸酶抑制剂的生物测定。
Arch Pharm (Weinheim). 2020 Jan;353(1):e1900174. doi: 10.1002/ardp.201900174. Epub 2019 Oct 28.
7
Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.设计和合成 4-烷基-2-氨基(乙酰氨基)-6-芳基-1,3-噻嗪衍生物作为流感神经氨酸酶抑制剂。
Arch Pharm (Weinheim). 2013 Sep;346(9):635-44. doi: 10.1002/ardp.201300122. Epub 2013 Aug 7.
8
Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.新型1,3,4-恶二唑衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 2022 Mar 1;57:116647. doi: 10.1016/j.bmc.2022.116647. Epub 2022 Jan 30.
9
Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.新型 N-取代奥司他韦衍生物作为有效的流感神经氨酸酶抑制剂:设计、合成、生物评价、ADME 预测和分子对接研究。
Eur J Med Chem. 2019 Nov 15;182:111635. doi: 10.1016/j.ejmech.2019.111635. Epub 2019 Aug 22.
10
Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.新型奥司他韦衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2017 Dec 15;27(24):5429-5435. doi: 10.1016/j.bmcl.2017.11.003. Epub 2017 Nov 4.

本文引用的文献

1
A comprehensive review on the antiviral activities of chalcones.查耳酮类化合物抗病毒活性的综合评价
J Drug Target. 2021 Apr;29(4):403-419. doi: 10.1080/1061186X.2020.1853759. Epub 2020 Dec 16.
2
Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.虚拟筛选鉴定诃子酸为 M2(S31N)病毒离子通道和甲型流感病毒抑制剂
Molecules. 2020 Jun 24;25(12):2903. doi: 10.3390/molecules25122903.
3
Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment.具有癌症治疗治疗潜力的 SHP2 别构抑制剂。
J Med Chem. 2017 Dec 28;60(24):10205-10219. doi: 10.1021/acs.jmedchem.7b01520. Epub 2017 Dec 7.
4
QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.基于定量构效关系驱动的具有抗结核活性的强效查尔酮衍生物的设计、合成与发现。
Eur J Med Chem. 2017 Sep 8;137:126-138. doi: 10.1016/j.ejmech.2017.05.026. Epub 2017 May 10.
5
Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.新型 1-(7-乙氧基-1-苯并呋喃-2-基)取代查尔酮衍生物的合成、表征及抗癌活性。
Eur J Med Chem. 2017 Aug 18;136:212-222. doi: 10.1016/j.ejmech.2017.05.017. Epub 2017 May 5.
6
A Potent, Selective, and Orally Bioavailable HCV NS5A Inhibitor for Treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazol-2-yl)pyrrolidine-2-carboxamide.一种用于治疗丙型肝炎病毒的强效、选择性且口服生物可利用的丙型肝炎病毒NS5A抑制剂:(S)-1-((R)-2-(环丙烷甲酰胺基)-2-苯基乙酰基)-N-(4-苯基噻唑-2-基)吡咯烷-2-甲酰胺。
J Med Chem. 2017 Jan 12;60(1):228-247. doi: 10.1021/acs.jmedchem.6b00962. Epub 2016 Dec 28.
7
Origins of Resistance Conferred by the R292K Neuraminidase Mutation via Molecular Dynamics and Free Energy Calculations.通过分子动力学和自由能计算探究 R292K 神经氨酸酶突变赋予的耐药性起源。
J Chem Theory Comput. 2008 Sep 9;4(9):1526-40. doi: 10.1021/ct800068v.
8
Bat-derived influenza-like viruses H17N10 and H18N11.源自蝙蝠的类流感病毒H17N10和H18N11。
Trends Microbiol. 2014 Apr;22(4):183-91. doi: 10.1016/j.tim.2014.01.010. Epub 2014 Feb 26.
9
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.甲型流感病毒(H7N9)在不失体内毒力和传染性的情况下获得神经氨酸酶抑制剂耐药性。
Nat Commun. 2013;4:2854. doi: 10.1038/ncomms3854.
10
Synthesis and antiviral activity of substituted bisaryl amide compounds as novel influenza virus inhibitors.取代双芳酰胺类化合物的合成及作为新型流感病毒抑制剂的抗病毒活性。
Eur J Med Chem. 2012 Sep;55:117-24. doi: 10.1016/j.ejmech.2012.07.008. Epub 2012 Jul 14.